Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
03/2014
03/19/2014CN102940892B Preparation method of targeting porphyrin fluorescent molecule and gold nanorod dyad
03/19/2014CN102727893B Recombinant human endostatin liposome microbubble and application thereof in preparing medicament for inhibiting tumor angiogenesis under ultrasound mediation
03/19/2014CN102552145B Preparation method of artificial liposome
03/19/2014CN101360515B Fluorescent nanoparticles
03/18/2014US8673863 Glutathione-based delivery system
03/18/2014US8673554 Multiplex cell signalling assays
03/18/2014US8673319 Chimpanzee adenovirus vaccine carriers
03/18/2014US8673305 Methods of treatment with antibodies against the extracellular loops of C5aR
03/18/2014US8673270 RGD-containing peptidomimetics and uses thereof
03/18/2014US8673269 Halogenated phenols for diagnostics, antioxidant protection and drug delivery
03/18/2014US8673268 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
03/18/2014US8673267 Methods and products for in vivo enzyme profiling
03/18/2014US8673265 Carbonylporphyrins and uses thereof
03/18/2014US8672965 Nucleus replacement based on injectable PVA gels
03/18/2014CA2564737C Contrast agents for myocardial perfusion imaging
03/17/2014CA2826786A1 Multi-encapsulated formulations made with oxidized cellulose
03/13/2014WO2014039874A2 Methods and materials for reducing reticuloendothelial system clearance of particles from a subject
03/13/2014WO2014038829A1 Method for selectively activating magnetic nanoparticle and selectively activated magnetic nanoparticle
03/13/2014WO2014038558A1 Molecular assembly using branched amphiphilic block polymer, and drug transportation system
03/13/2014WO2014037941A1 Luminal administration of tag molecules for diagnostic applications
03/13/2014WO2014037498A2 Paramagnetic solid lipid nanoparticles (pslns) containing metal amphiphilic complexes for mri.
03/13/2014WO2013176292A3 Polymer, contrast agent for nuclear magnetic resonance analysis or magnetic resonance imaging using the polymer, compound and method of nuclear magnetic resonance analysis and method of magnetic resonance imaging using the polymer
03/13/2014WO2012119102A3 Homeopathic therapeutic method and compositions
03/13/2014US20140073885 Multi-channel medical imaging system
03/13/2014US20140072517 Fe(ii) sequestering agents and uses thereof
03/13/2014US20140072516 Methods for detecting enzyme activity using fluorescence lifetime imaging
03/13/2014US20140072514 Polytetrafluoroethylene co-polymer emulsions
03/13/2014US20140072511 Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy
03/13/2014US20140072510 Synthetic Scaffolds for Metastasis Detection
03/13/2014DE102012018076A1 Klebender Funktionsstreifen zur transkutanen Fluoreszenzmessung sowie zugehörige Herstellungsverfahren und Verwendungen Adhesive strip function for transcutaneous measurement of fluorescence and related manufacturing methods and uses
03/12/2014EP2705855A1 Photodynamic therapy or diagnostic agent, using infrared-spectrum light
03/12/2014EP2705012A1 Radiolabeled amino acids for diagnostic imaging
03/12/2014EP2704758A1 Device with echogenic coating
03/12/2014EP2704757A1 Echogenically enhanced device
03/12/2014CN103627673A Human brain glioma cell line, and establishing method and application thereof
03/12/2014CN103626846A Ligand polypeptide specifically combined with MDSCs (Myeloid-Derived Suppressor Cells) and drug delivery system
03/12/2014CN103623438A Carbon dioxide microbubble ultrasonic pericardial cavity contrast medium
03/12/2014CN103623437A Nano probe material for imaging, and preparation method and application thereof
03/12/2014CN103623436A Magnetic rare earth nanoparticle with biocompatibility, preparation method thereof, and applications of magnetic rare earth nanoparticle in magnetic resonance imaging
03/12/2014CN103623435A Nanometer magnetic resonance contrast material, nanometer magnetic resonance contrast agent and preparation method of nanometer magnetic resonance contrast agent
03/12/2014CN103623434A Compound iodine staining diagnostic kit set for esophageal mucosa
03/12/2014CN103623433A Modified zebra fish drug metabolism modeling method
03/12/2014CN103623432A Preparation of homogenate in rat jejunum state
03/12/2014CN103623430A Preparation method and application of targeted co-supported drug delivery system nano-particles based on polylactic-co-glycolic acid
03/12/2014CN103623428A Transformation method and application of recombinant virus containing ER beta
03/12/2014CN103623418A Fluorescently-labeled tumor targeting tracer, and preparation method and application thereof
03/12/2014CN103290019B Atherosclerosis targeting aptamer as well as preparation method and application thereof
03/12/2014CN102202694B Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to same
03/06/2014WO2014036402A1 Container with concentrated substance and method of using the same
03/06/2014WO2014036037A1 N-boc-dendrimers and their conjugates
03/06/2014WO2014035712A1 Benzopyrylium compounds
03/06/2014WO2014035341A1 Nanoparticulate contrast agent
03/06/2014WO2014033127A1 Vaginal preparation for the diagnosis of human female uterotubal patency and function for the purpose of fertilization of gametes
03/06/2014WO2014012042A8 Intralipid as a contrast agent to enhance subsurface blood flow imaging
03/06/2014US20140066761 Optoacoustic-Ultrasonic Contrast Agents with Enhanced Efficiency
03/06/2014US20140065649 Test systems and methods for identifying and characterising lipid lowering drugs
03/06/2014US20140065233 Injectable microspheres for dermal augmentation and tissue bulking
03/06/2014US20140065148 Treatment methods using antibodies to aminophospholipids
03/06/2014US20140065077 Container with concentrated substance and method of using the same
03/06/2014US20140065076 Container with concentrated substance and method of using the same
03/06/2014US20140065075 Targeted contrast agents and uses thereof
03/06/2014US20140065074 Method of tracking growth and metastasis of specific cells in vivo
03/06/2014US20140065073 Imaging agents and methods of use thereof
03/06/2014US20140065072 Modulation of Telomere Length in Telomerase Positive Cells and Cancer Therapy
03/06/2014US20140065071 Sincalide Formulations
03/06/2014US20140065067 Radiopaque iodinated products intended for use medical imaging and their methods
03/06/2014US20140065066 Imaging and therapeutic method using monocytes
03/06/2014DE102012017044A1 Multi-contrast agent useful in fillers for bone and teeth, comprises particles made of sheath comprising contrast agent for computed tomography and core comprising contrast agent for magnetic resonance imaging
03/05/2014EP2703495A1 Method for detecting cancer cell using fluorescently labeled l-glucose derivative, and cancer cell-imaging agent comprising fluorescently labeled l-glucose derivative
03/05/2014EP2701747A2 Hsp90 combination therapy
03/05/2014EP2701740A1 Microparticle and/or nanoparticle vaccine for prophylactic and/or therapeutic application
03/05/2014EP2701625A1 Coating for improving the ultrasound visibility
03/05/2014CN103619911A Cross-linked poly-E-lysine non-particulate support
03/05/2014CN103619802A Novel lipidomimetic compounds and uses thereof
03/05/2014CN103613574A Medical application of 2, 2-dimethyl thiochromanone compounds containing piperazine structures and analogues thereof
03/05/2014CN103611173A Imaging agent for gastrointestinal B-ultrasonic examination
03/05/2014CN103611172A Nanorealgar-carrying magnetic albumin nanospheres and preparation method thereof
03/05/2014CN103611171A Non-ionic multi-nuclear magnetic resonance imaging contrast medium taking tetrabenzoylmethane as interconnect and preparation method thereof
03/05/2014CN103611170A Preparation method of W18O49 nanoparticles having both photothermal therapy and CT (Computerized Tomography) radiography functions
03/05/2014CN103611168A Composite magnetic nanoparticles for targeted therapy of liver cancer and preparation method thereof
03/05/2014CN102228690B Application of antifolic in constructing mouse model with neural tube defects (NTDs)
03/05/2014CN101600461B Formation and rejuvenation of organs and alcohol damaged organ regeneration through stem cell nutrients
03/04/2014US8664181 Dual acting prodrugs
03/04/2014US8663926 Detection of anthrax pathogenicity factors
03/04/2014US8663606 Method of producing a cationic liposomal preparation comprising a lipophilic compound
03/04/2014US8663602 Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
03/04/2014US8663600 Diagnosis of prostate cancer
03/04/2014US8663598 Anti-human transferrin receptor antibody and uses thereof
02/2014
02/27/2014WO2014031727A1 Ferritin-based tumor targeting agent, and imaging and treatment methods
02/27/2014WO2014029814A1 Nanoparticulate compositions for diagnostic imaging
02/27/2014WO2014029813A1 Nanoparticulate compositions for diagnostic imaging
02/27/2014WO2014029756A1 Cholyl-l-lysyl-fluorescein assay
02/27/2014US20140056822 DNA Dendrimers as Thermal Ablation Devices
02/27/2014US20140056821 Nanoparticulate compositions for diagnostic imaging
02/27/2014US20140056820 Transport agents for crossing the blood-brain and into brain cancer cells and methods of use thereof
02/27/2014US20140056819 Nanoparticulate compositions for diagnostic imaging
02/27/2014US20140056817 Photodynamic therapy or diagnostic agent, using infrared-spectrum light
02/27/2014US20140056816 Implants and biodegradable fiducial markers
02/27/2014US20140056815 Methods to regulate polarization and enhance function of cells
02/27/2014US20140056814 Method of constructing animal having cancer cells transplanted thereinto
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 354